Earnings Dr Reddy's posts loss of Rs 569.7 crore in Q3FY20 on impairment of generic Nuvaring drug Updated : January 27, 2020 01:39 PM IST Total revenue during the quarter grew 13.86 percent to Rs 4,383.8 crore from Rs 3,850 crore YoY. In Q3FY20, company’s EBITDA increased by 24.1 percent to Rs 1,073.7 crore from Rs 865.2 crore while EBITDA margin rose 200 bps to 24.5 percent YoY. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.